Prince Charles formally opened a new 1 billion pound AstraZeneca research and development (R&D) facility in Cambridge on Tuesday (November 23), as the company
aims to fuel the growth of its drug pipeline.
AstraZeneca has supplied two billion doses of its Covid-19 vaccine, developed at Oxford University, and is also looking to bring a preventative antibody cocktail
against Covid-19 to market.
Prince Charles, son of Queen Elizabeth and heir to the throne, saw an exhibit on the pandemic and a demonstration of how augmented reality headsets can help with
lab work, before hearing about the company's net-zero targets.
"The last two years have been some of the most difficult of a generation," Prince Charles said in a speech.